Henry M. Lemon, M.D., F.A.C.P.; P. J. Mozden, M.D.
This content is PDF only. Please click on the PDF icon to access.
Toxicity that has handicapped the utilization of 5-fluorouracil for cancer chemotherapy has been greatly reduced by intravenous infusion of drug in 5% dextrose over an 8-hour period, permitting increased dosage and use with radiation therapy. This report evaluates over 100 slowly infused patients in whom moderate to severe toxicity occurred in only 6% with doses up to 25 g in as many days. Objective remissions attributed to drug alone were noted in 10%, with another 20% responding to combination therapy using X ray or steroids. Adenocarcinoma of the rectum and colon, breast, and ovary were most often responsive, with relief
Lemon HM, Mozden PJ. Reduction of Toxicity of 5-Fluorouracil Cancer Chemotherapy.. Ann Intern Med. ;60:333. doi: 10.7326/0003-4819-60-2-333_2
Download citation file:
Published: Ann Intern Med. 1964;60(2_Part_1):333.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use